Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neutrophil Enzyme Digests Carbon Nanotubes

By LabMedica International staff writers
Posted on 19 Apr 2010
Researchers have found that the human neutrophil enzyme myeloperoxidase (hMPO) is able to breakdown and detoxify carbon nanotubes, a finding that paves the way for their use as a drug delivery mechanism.

Investigators at the University of Pittsburgh (PA, USA) and colleagues from several other institutions exposed carbon nanotubes to myeloperoxidase in vitro, in neutrophil cultures, and in macrophage cultures. More...
To increase the uptake of the nanotubes by neutrophils they were first coated with immunoglobulins.

Results reported in the April 4, 2010, online edition of the journal Nature Nanotechnology showed that incubation of single-walled nanotubes with hMPO and hydrogen peroxide resulted in degeneration of the nanotubes within 24 hours. This process could be accelerated by the addition of sodium chloride, which generated hypochlorite, a strong oxidizing compound known to break down nanotubes.

Native or immunoglobulin-coated nanotubes were introduced into neutrophil or macrophage cell cultures. After 12 hours in the neutrophil culture, essentially all the coated nanotubes were degraded as compared to only about 30% of the native nanotubes. In contrast, after two days in the macrophage culture only about 50% percent of the coated nanotubes had degenerated. The biodegraded nanotubes did not generate an inflammatory response when aspirated into the lungs of mice.

"The successful medical application of carbon nanotubes relies on their effective breakdown in the body, but carbon nanotubes also are notoriously durable,” said first author Dr. Valerian Kagan, professor of environmental and occupational health at the University of Pittsburgh. "The ability of hMPO to biodegrade carbon nanotubes reveals that this breakdown is part of a natural inflammatory response. The next step is to develop methods for stimulating that inflammatory response and reproducing the biodegradation process inside a living organism.”

Related Links:
University of Pittsburgh



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.